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Abstract
Background. Positive end-expiratory pressure (PEEP) is widely used to improve oxygenation and prevent alveolar collapse in
mechanically ventilated patients with the acute respiratory distress syndrome (ARDS). Although PEEP improves arterial oxy-
genation predictably, high-PEEP strategies have demonstrated equivocal improvements in ARDS-related mortality. The
effect of PEEP on tissue oxygen delivery is poorly understood and is difficult to quantify or investigate in the clinical
environment.
Methods. We investigated the effects of PEEP on tissue oxygen delivery in ARDS using a new, high-fidelity, computational
model with highly integrated respiratory and cardiovascular systems. The model was configured to replicate published clin-
ical trial data on the responses of 12 individual ARDS patients to changes in PEEP. These virtual patients were subjected to
increasing PEEP levels during a lung-protective ventilation strategy (0–20 cm H2O). Measured variables included arterial oxy-
genation, cardiac output, peripheral oxygen delivery, and alveolar strain.
Results. As PEEP increased, tissue oxygen delivery decreased in all subjects (mean reduction of 25% at 20 cm H2O PEEP),
despite an increase in arterial oxygen tension (mean increase 6.7 kPa at 20 cm H2O PEEP). Changes in arterial oxygenation
and tissue oxygen delivery differed between subjects but showed a consistent pattern. Static and dynamic alveolar strain
decreased in all patients as PEEP increased.
Conclusions. Incremental PEEP in ARDS appears to protect alveoli and improve arterial oxygenation, but also appears to
impair tissue oxygen delivery significantly because of reduced cardiac output. We propose that this trade-off may explain
the poor improvements in mortality associated with high-PEEP ventilation strategies.
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Respiration and the Airway
The incidence of acute respiratory distress syndrome (ARDS)
has been estimated at 70 per 100 000 patients yr1,1,2 with a
lethal outcome in 55% of patients.3 The global burden of the dis-
ease was estimated as 5.5 million patients yr1 requiring inten-
sive care unit admission and mechanical pulmonary
ventilation.4
The rationale for the application of PEEP during mechanical
ventilation of the lungs of patients with ARDS is to prevent
alveolar collapse, reducing injurious alveolar shear stresses and
improving ventilation–perfusion matching, and thus, arterial
oxygenation.5,6 Studies investigating the effect of PEEP have
consistently shown an improvement in oxygenation and pul-
monary compliance.5,7–10 Survival benefit was seen in patients
when PEEP was assigned based on oxygen requirements in com-
bination with low vs traditional tidal volume ventilation,11 and
some risk reduction was shown in a pooled subgroup analysis
when patients were stratified based on ARDS severity.12 Despite
this, the results of four large studies examining high-PEEP strat-
egies in ARDS have demonstrated an equivocal effect on mortal-
ity,13–16 confirmed after meta-analysis.12 Consequently, it is
unclear who might benefit from the application of PEEP; clinical
investigation has, to date, failed to provide a conclusive answer.
High levels of positive airway pressure throughout the respi-
ratory cycle have the potential to impair cardiac performance,
manifested as a reduced cardiac output.17–20 This is a result of
increased right ventricular afterload, reduced left ventricular
preload, and reduced biventricular compliance.21 It is credible
that PEEP-induced reduction in cardiac output may outweigh
the benefit of improved arterial oxygenation, resulting in
reduced organ oxygen delivery (DO2 ), and this was suggested by
the early work by Suter and colleagues22 examining the effect of
PEEP on lung compliance. Given the difficulty of accurately
measuring oxygen delivery in vivo, arterial oxygenation is the
usual, clinical target for ventilatory optimization; thus, we may
remain unaware of the quantitative effect that PEEP might have
with respect to oxygen delivery.
Acute respiratory distress syndrome is a heterogeneous dis-
ease process, with widely varying cause and progression. This
makes it an ideal candidate for high-fidelity modelling studies
that can investigate the benefits and hazards of PEEP across
individuals in the safe, cost-effective, reproducible in silico
environment.
Methods
Our study uses a highly integrated computer simulation model
of the pulmonary and cardiovascular systems that has recently
been developed by our group.23,24 The model includes 100 inde-
pendently configured alveolar compartments and 19 cardiac
compartments. Aspects of the model related to pulmonary
pathophysiology have been validated previously,23,25–28 includ-
ing ARDS.29,30 This model was integrated with a multicompart-
mental, contractile cardiovascular model with pulsatile blood
flow and ventilation-affected, transalveolar blood flow. The car-
diac section of the model consists of two contractile ventricles,
with atria modelled as non-contractile, low-resistance, high-
compliance compartments. The mathematical principles under-
pinning the model are detailed in the Supplementary appendix.
Cardiopulmonary interactions are modelled in a number of
ways. Ventricular contractility is modelled as a truncated sine-
wave varying ventricular elastance over time. Intrapulmonary
pressure is transmitted variably across ventricular walls such
that lung inflation reduces ventricular compliance; in this study,
85% of intrapulmonary pressure was transmitted across the
ventricles. Transalveolar blood flow is governed by pulmonary
arterial pressure and by transalveolar vasoresistance; this
resistance is affected dynamically in each alveolar compart-
ment by alveolar volume (causing longitudinal stretch) and
alveolar pressure (causing compression).
Published, clinical data were used to validate the responses
of the integrated model against those of individual ARDS
patients. Global optimization algorithms were used to configure
the model parameters (e.g. microbronchial resistances, transal-
veolar vasoresistances, and alveolar compliance) against pub-
lished clinical trial data on tidal volume, respiratory rate,
haemoglobin concentration, metabolic rate, and pulmonary
shunt fraction, in order to replicate arterial blood gas values.
Once these static configurations were determined, cardiovascu-
lar settings in the model (e.g. ventricular contractility, compart-
mental blood volumes, arterial resistances, and ventricular
splinting) were manually tuned to match reported dynamic
changes in cardiovascular performance during PEEP variation.
Where there were deficiencies in the published data sets, histor-
ically appropriate patient characteristics and clinical data were
used to create a plausible estimate of the missing data values.
For example, if haemoglobin concentration was not reported, it
was estimated to be 100 g litre1 (this being a common clinical
target before the publication of the TRICC study in 1999);31
where ventilation mode was not specified, it was assumed to be
volume controlled with a constant inspiratory flow and
inspiratory-to-expiratory ratio of 1:2 (this being reported in
many clinical trials investigating ventilation strategies for
ARDS).11
Initial matching was against data derived from a single
ARDS patient reported by Dantzker and colleagues.17 This
patient had severe ARDS, with arterial oxygen partial pressure
(PaO2 )-to-fractional inspired O2 ratio of 87 mm Hg (11.6 kPa), and
underwent a four-stage incremental PEEP trial. Thereafter, the
same process was carried out using the clinical data sets of
Jardin and colleagues18 and Pinsky and colleagues;20 for each of
these clinical studies, the model was matched to the average
cardiopulmonary state of each study population and subjected
to the published incremental PEEP trials. Model outputs were
compared against the data collected in the clinical studies.
Model simulation and comparison of results with the histori-
cal data were carried out by two independent investigators in
different universities, allowing corroborated evaluation of the
simulations. Full details of the methodology used in validating
Editor’s key points
• Positive end-expiratory pressure is widely used in
mechanically ventilated patients with the acute respira-
tory distress syndrome (ARDS), but the effect of PEEP on
tissue oxygen delivery is not known.
• The authors investigated the effects of PEEP on tissue
oxygen delivery in ARDS.
• Increasing PEEP increased arterial oxygen tension but
decreased tissue oxygen delivery.
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the model against clinical data are provided in the
Supplementary appendix.
When accurate reproduction of results was achieved, we
were able to proceed to prospective testing of the effects of an
incremental PEEP trial on DO2 in a variety of matched in silico
subjects with various ARDS disease configurations.
PEEP trial simulation protocol
An in silico bank of 12 ARDS subjects was created by configuring
parameters in the model to match published pathophysiological
data from several publications.17,18,20,32,33 An additional
‘healthy’ subject was configured to provide a baseline response
(Table S3 in the Supplementary appendix).
The cardiovascular model parameters used in the validation
process were used to initialize the cardiovascular system model
for prospective testing, and these parameters are reported in
the Supplementary appendix (Table S6).
Modelled patients received pulmonary ventilation using set-
tings in line with recommendations from the ARDSnet study;11
using square-wave pressure-controlled ventilation, with a con-
stant inspiratory-to-expiratory ratio of 1:2 and ventilatory rate
of 10 bpm. Inspiratory pressure was adjusted to maintain a tidal
volume between 450 and 600 ml (6–8 ml kg1) to maintain arte-
rial carbon dioxide partial pressure (PaCO2 ) between 4 and 10 kPa
based on the findings of early tidal volume and permissive
hypercapnia studies.34–36 The initial fractional inspired O2 from
the matching process was fixed and kept constant throughout;
this ensured that any observed increase in oxygenation would
be as a result of alveolar recruitment. The PEEP started at
0 cm H2O and increased by 5 cm H2O every 10 min to a maxi-
mum of 20 cm H2O, before finally returning to 0 cm H2O (see
Table 1).
The following outputs were recorded every 10 ms: arterial
haemoglobin oxygen saturation (SaO2 ), mixed venous haemoglo-
bin oxygen saturation (SvO2 ), PaO2 , PaCO2 , arterial pH, alveolar
recruitment (the fraction of alveoli receiving non-zero ventila-
tion), cardiac output, aortic blood pressure, arterial oxygen
delivery (DO2 ), and dynamic alveolar strain (as a surrogate for
the risk of alveolar injury) as suggested by Protti and col-
leagues.37 Data are presented as averages throughout the ninth
minute after each change in PEEP (i.e. during the minute preced-
ing the next PEEP value).
Model simulations were run on a 64-bit Intel Core i7 3.7 GHz
Windows 7 personal computer, running Matlab version R2014a
(8.3.0.532; MathWorks Inc., Natick, MA, USA). Research ethics
committee approval was not sought, because the data used for
model development and validation were sourced from studies
that had already received ethical approval. Simulation protocols
were performed purely in silico without participation from
human subjects.
Results
Results of the initial calibration are shown in the Supplementary
appendix; Fig. S4 shows the close fit of the model to data from
patient-8 from Dantzker and colleagues17 against cardiac output,
ventricular stroke volume, pulmonary vascular resistance, and
PaO2 . Figures S5 and S6 in the Supplementary appendix show
simulation performance against the clinical results from Jardin
and colleagues18 and Pinsky and colleagues,20 respectively.
Modelled results were consistently very close to those of clinical
studies, indicating acceptable validity of the models in reproduc-
ing dynamic, in vivo, multi-organ behaviour.
Table 1 shows the average value of each measured parame-
ter in all 12 in silico subjects at each PEEP setting during the
implemented PEEP trial simulation protocol. The results pre-
sented show the mean and SD for all 12 in silico subjects at each
PEEP setting for each reported parameter. Figures displaying the
behaviour of each subject in the group are provided in the
Supplementary appendix.
In all but the healthy subject, PEEP increased arterial oxygena-
tion. At 20 cm H2O PEEP, in comparison with the value at
0 cm H2O PEEP, the following changes were observed; each is
expressed as mean (SD, range): PaO2 increased by 6.9 kPa
(8.77, 0.47 to 27.0 kPa; Fig. 1); SaO2 increased by 3.9% (6.36, 4.33
to 19.4 kPa); recruited alveolar compartments increased by 18%
(10.3, 0–42.8%; Fig. 2); mean arterial pressure reduced by
22 mm Hg (1.79, 9.20–15.5 mm Hg); cardiac output reduced by 1.85
litres min1 (0.17, 1.46–2.11 litres min1); and oxygen delivery
reduced by 0.20 litres min1 (0.20, 0.07–0.46 litres min1; Fig. 3).
Average dynamic alveolar strain (i.e. alveolar tidal volume/
end-expiratory volume) decreased with the incremental addi-
tion of PEEP, with an absolute average reduction in strain ratio
of 0.314, representing a relative average reduction in strain of
43% across the group; however, the exact relationship between
Table 1 Summary of findings and trial protocol. Data presented are the mean average (SD) values at each PEEP value for all 12 simulated
patients. CO, cardiac output; DO2 , oxygen delivery; MAP, mean aortic arterial pressure; PaCO2 , arterial partial pressure of carbon dioxide;
PaO2 , arterial partial pressure of oxygen; SaO2 , arterial oxygen saturation; SvO2 , mixed venous oxygen saturation; VT, tidal volume
Parameter PEEP 0 cm H2O PEEP 5 cm H2O PEEP 10 cm H2O PEEP 15 cm H2O PEEP 20 cm H2O PEEP 0cm H2O
VT (ml) 488 (68.6) 503 (63.3) 507 (78.9) 520 (74.4) 545 (72.6) 488 (68)
MAP (mm Hg) 89.4 (2.12) 85.4 (1.70) 82.2 (1.22) 79.4 (1.05) 76.9 (0.99) 89.3 (2.11)
CO (ml min1) 6523 (197) 6008 (153) 5552 (95.8) 5106 (77.4) 4669 (74.3) 6520 (199)
SaO2 (%) 89.2 (7.26) 90.2 (6.26) 89.5 (7.17) 93.1 (7.52) 93.1 (8.47) 89.1 (7.33)
PaO2 (kPa) 8.90 (2.88) 9.54 (2.99) 9.86 (3.79) 11.25 (3.86) 15.8 (8.78) 9.36 (2.77)
PaCO2 (kPa) 5.63 (0.99) 6.26 (1.54) 6.61 (1.83) 6.59 (1.89) 6.37 (1.96) 6.80 (1.92)
SvO2 (%) 56.0 (1.54) 54.3 (1.50) 50.6 (1.66) 50.0 (1.75) 48.3 (2.00) 56.0 (1.54)
DO2 (ml min
1) 792 (271) 736 (242) 676 (223) 636 (200) 591 (185) 791 (272)
Recruitment (%) 66.2 (12.8) 70.3 (12.3) 73.0 (12.4) 78.1 (11.2) 83.7 (11.4) 66.3 (12.8)
Dynamic strain (ratio) 0.74 (0.28) 0.60 (0.18) 0.56 (0.17) 0.49 (0.16) 0.43 (0.18) 0.77 (0.27)
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PEEP and strain varied within the group (Fig. 4). The relationship
between alveolar unit recruitment and dynamic alveolar strain
ratio for all PEEP settings in all 12 in silico subjects is shown in
Fig. S7 in the Supplementary appendix.
Discussion
The use of a highly integrated pulmonary and cardiovascular
computer simulation allowed systematic investigation of the
effects of incremental PEEP on the cardiopulmonary systems in
an in silico population of ARDS patients.
In silico simulation allows repeated, systematic investigation,
without confounding by unquantified (‘silent’) interpatient vari-
ability or variability over time. The use of a population of mod-
elled subjects allows greater confidence in extrapolating our
findings to patients. The standardization allowed by an in silico
population reduced ‘data noise’, and we anticipate that prag-
matic and ethical issues would prevent a similar investigation
in vivo.
From previous work,30 it was expected that improved oxy-
genation would arise from alveolar recruitment. There is
currently no standardized duration for a clinical trial of incre-
mental PEEP; however, there are recommendations for the dura-
tion of recruitment manoeuvres lasting from a few seconds38 to
several minutes.5,6 It was observed that after ventilation
changes, the model required a period of equilibration, during
which alveolar compartment recruitment occurred, and cardiac
performance and gas exchange stabilized. On this basis, the
duration of each level of PEEP was set at 10 min, approximately
twice the time required for 98% equilibration.24
Increasing PEEP markedly increased PaO2 ; however, the
accompanying increase in haemoglobin saturation was smaller,
reflecting the finite oxygen-binding capacity of haemoglobin.
The greatest increase in PaO2 was observed in patients with the
worst hypoxaemia at 0 cm H2O PEEP, in whom the supplemental
airway pressure caused the greatest recruitment of collapsed
alveoli (Fig. 2); this was supported by the demonstration that
PEEP-induced improvement in oxygenation reversed when PEEP
returned to 0 cm H2O.
Cardiac output decreased relatively consistently in all sub-
jects in response to incremental PEEP. This was attributable to a
combination of ventricular splinting by the distended lung,
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Fig 1 Arterial partial pressure of oxygen (PaO2 ) over time during incremental PEEP trial. Filled blocks with errors bars represent group mean and SD for all 12 in silico
patients (left axis). Dashed lines show the average ventilation metrics during the incremental PEEP trial (PaWP, peak airway pressure; MaWP, mean airway pres-
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reducing right ventricular preload, and increased pulmonary
vascular resistance, increasing right ventricular afterload; both
serving to reduce right ventricular ejection and left ventricular
filling.24 In all patients, the PEEP-induced reduction in cardiac
output outweighed the induced improvement in oxygenation,
such that increasing PEEP decreased DO2 in every modelled
circumstance.
There was a decrease in dynamic strain ratios during the
PEEP trial, with return to baseline levels on removal of PEEP. The
degree of dynamic strain reduction appeared to be related to the
presence of collapsed but recruitable alveolar units, and this is
best illustrated graphically, where strain is plotted against
recruitment (Fig. S7 in the Supplementary appendix).
Examination of the individual patient data shows that an
increase in PEEP caused strain to increase, until the threshold
opening pressure was achieved for the collapsed lung units;
when new alveolar units opened, the total distending force was
distributed amongst more alveoli, thereby reducing the average
strain for the whole lung.
Death in patients with ARDS rarely appears to be attributable
to respiratory failure per se; rather, the majority of deaths are
attributable to the underlying ARDS trigger or disease progres-
sion to systemic inflammatory response syndrome or multiple
organ failure.39 This is caused in part by biological lung trauma
(‘biotrauma’) caused by alveolar epithelial damage, resulting in
the release of pulmonary cytokines,39 but may also be com-
pounded by systemic release of inflammatory cytokines secon-
dary to inadequate organ perfusion.
Findings from this investigation offer an explanation for the
apparent lack of mortality benefit in studies examining high-
PEEP strategies in patients with ARDS,13–16 and for the fact that
subgroup analyses indicate that those with the severest disease
may benefit most from PEEP.12 Careful examination of each in
silico patient demonstrates that those with the worst starting
hypoxaemia and greatest number of recruitable alveolar com-
partments exhibited the greatest improvement in oxygenation
compared with reduction in cardiac output. Likewise, those
with the largest number of recruitable compartments also
exhibited the greatest reduction in the average dynamic lung
strain.
The recent mediation analysis of large randomized control
studies by Amato and colleagues40 has suggested that high-
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PEEP strategies may not always be protective, and high plateau
pressures may not necessarily add mortality risk in ARDS. The
protocol for our modelling study was based on stepwise escala-
tion of PEEP with fixed driving pressure (using a pressure-
controlled mode of ventilation), and we were therefore unable
to investigate variation in our recordings based on fixed PEEP vs
matching plateau pressure. However, the results do demon-
strate different proportions of alveolar compartment recruit-
ment and dynamic lung strain on an individual patient basis
for an almost uniform set of driving pressures across the
group. This is most evident in Figs S25, S26, and S27 in the
Supplementary appendix. Modelling may provide the ideal
opportunity to examine further the variation in driving pressure
during ventilation in ARDS and its relationship to oxygenation,
ventilation, oxygen delivery, and lung mechanics.
Our demonstration of a consistent decrease in DO2 in
response to PEEP in an in silico population is novel. The influence
of PEEP on cardiovascular performance outweighed, in every
patient, the improvement in oxygenation in an experimental
population with deliberately varied ventilation–perfusion mis-
matching and alveolar collapse. The notion that PEEP can be
categorized in terms of improvement in oxygenation, reduction
of shunt fraction, and impact on the cardiovascular system is
not in itself new.41 There seems to be agreement that PEEP
should be an addition to ventilation strategy in ARDS,42–44
although there is still much debate concerning the determina-
tion of the correct level of PEEP for use in patients with ARDS.45
Titration of PEEP to cardiovascular performance requires
estimation of the cardiac output; however, the use of the ‘gold-
standard’ pulmonary artery catheter has decreased dramati-
cally over the last decade,46,47 and despite surveys of practice
indicating the facility to use flow monitoring in critical care,
only a small proportion of critical care units seem to do so on a
routine basis.48
Our study had several limitations that should be noted. The
model was calibrated and validated against data from historical
studies. It is plausible that the cardiovascular side-effects of his-
torical drugs and dosage required to produce levels of sedation
deep enough to allow the traditional high tidal volume ventila-
tion, with or without neuromuscular block, may completely
obtund normal cardiovascular system baroreceptor reflexes.
Indeed, the aforementioned historical studies consistently
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report that heart rate did not change significantly throughout
the duration of their interventions;17–20 it was therefore deemed
appropriate to fix the heart rate at 100 beats min1 for this
investigation.
The importance of atrial contraction for ventricular filling is
poorly understood. The majority of experimental data relate to
lower mammalian studies, human studies with small numbers of
volunteers, and stable patients, with possible confounding factors
from study design and timing of follow-up.49 Consequently, in
this study we used a lumped model of atrial and ventricular con-
traction; in the context of a fixed heart rate and the assumption
of sinus rhythm and normal heart valves, we feel that this has
minimal impact on the applicability of our results.
Conclusion
The highly integrated cardiopulmonary model used in this
study was able to match accurately the cardiorespiratory inter-
actions of individual patients with ARDS receiving mechanical
ventilation, allowing in-depth and controlled investigation of
key outcome parameters using data that may not be routinely
scrutinized in daily clinical practice.
Our results show that changing the ventilation strategy to
improve commonly monitored oxygenation indices and
increase alveolar protection by preserving the open lung may,
counterintuitively, be at the hidden expense of reducing global
oxygen delivery, particularly in patients with less severe ARDS.
In clinical practice, PEEP-response trials should ideally include
measurement and titration to DO2 in order to allow personalized
application of optimal PEEP to maximize alveolar protection
while minimizing the reduction in global oxygen delivery. Such
a personalized approach might yield substantial improvements
in the effectiveness of our existing therapeutic strategies.
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